Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-053558

Chief Scientific Officer sold 6,000 shares at $5.08 ($30,460)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Monahan Joseph Chief Scientific Officer 2023-10-23 Sale 10b5-1 −6,000 $5.08 $30,460 129,724 D: show line 1 in the form
Open-market sales · 6,000 sh · avg $5.08 · $30,460
Loading xslF345X05/doc4.xml…